These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15851655)

  • 1. Recruiting dendritic cells to improve antibody therapy of cancer.
    Dhodapkar KM; Dhodapkar MV
    Proc Natl Acad Sci U S A; 2005 May; 102(18):6243-4. PubMed ID: 15851655
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms.
    Courtenay-Luck NS; Epenetos AA; Moore R; Larche M; Pectasides D; Dhokia B; Ritter MA
    Cancer Res; 1986 Dec; 46(12 Pt 1):6489-93. PubMed ID: 2430699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immunological enhancement.
    Cruse JM; Lewis GK; Whitten HD; Watson ES; Fields JF; Adams ST; Harvey GF; Paslay JW; Porter M
    Prog Exp Tumor Res; 1974; 19():110-56. PubMed ID: 4140539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies: better knowledge for a better use].
    Abès R; Dutertre CA; Teillaud JL
    Med Sci (Paris); 2009 Dec; 25(12):1011-9. PubMed ID: 20035672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will sialylation change intravenous immunoglobulin therapy in the future?
    Käsermann F; Campbell IK
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):100-2. PubMed ID: 25546779
    [No Abstract]   [Full Text] [Related]  

  • 6. Mapping the functional topography of Fc gamma with monoclonal antibodies: localization of epitopes interacting with the binding sites of Fc receptor on human K cells.
    Sármay G; Jefferis R; Klein E; Benczur M; Gergely J
    Eur J Immunol; 1985 Oct; 15(10):1037-42. PubMed ID: 2414110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology. The adjuvant effects of antibodies.
    Smyth MJ; Kershaw MH
    Science; 2011 Aug; 333(6045):944-5. PubMed ID: 21852479
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.
    Iannello A; Ahmad A
    Cancer Metastasis Rev; 2005 Dec; 24(4):487-99. PubMed ID: 16408158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of B cells in vivo by a Fab/Fc fragment of a monoclonal anti-IgD antibody requires an interaction between the antibody fragment and a cellular IgG Fc receptor.
    Goroff DK; Finkelman FD
    J Immunol; 1988 May; 140(9):2919-24. PubMed ID: 2966202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the specific feedback suppression mechanism in the primary anti-SRBC antibody responses].
    Thkahashi S
    Hokkaido Igaku Zasshi; 1982 Jul; 57(4):467-77. PubMed ID: 6983487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossreaction of monoclonal antiidiotypic antibodies specific for human antithyroglobulin antibody with the Fc portion of human IgG.
    Kojima K; Yamada T; Ohgaki S; Tanaka H
    J Rheumatol; 1988 Apr; 15(4):587-92. PubMed ID: 3397967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of T cell proliferation and lymphokine production by monoclonal antibody.
    Chang TW
    Lymphokine Res; 1982; 1(1):5-8. PubMed ID: 6821400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing tolerance and immunity: the role of dendritic cell and T cell subsets.
    Shklovskaya E; Fazekas de St Groth B
    Methods Mol Biol; 2007; 380():25-46. PubMed ID: 17876085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dendritic cells and cancer therapy].
    Baggers J
    Ugeskr Laeger; 2000 Oct; 162(44):5940-1. PubMed ID: 11094562
    [No Abstract]   [Full Text] [Related]  

  • 15. Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.
    Stubenrauch K; Mackeben K; Vogel R; Heinrich J
    Anal Biochem; 2012 Nov; 430(2):193-9. PubMed ID: 22935295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mix-up of Fc receptors in the response to monoclonal antibodies].
    Teillaud JL
    Med Sci (Paris); 2012 Jan; 28(1):11-3. PubMed ID: 22289817
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer immunotherapy of targeting angiogenesis.
    Hou J; Tian L; Wei Y
    Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible applications of antibodies or their genes in cancer therapy.
    Kuroki M; Huang J; Shibaguchi H; Tanaka T; Zhao J; Luo N; Hachimine K; Kinugasa T; Maekawa S; Enatsu S; Hamanaka W; Fukami T; Kuroki M
    Anticancer Res; 2006; 26(6A):4019-25. PubMed ID: 17195452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric antibody with dual Fc regions (bisFabFc) prepared by manipulations at the IgG hinge.
    Stevenson GT; Pindar A; Slade CJ
    Anticancer Drug Des; 1989 Mar; 3(4):219-30. PubMed ID: 2930624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology. Considering therapeutic antibodies.
    Vitetta ES; Ghetie VF
    Science; 2006 Jul; 313(5785):308-9. PubMed ID: 16857927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.